MBX Biosciences (MBX) Reiterated at Buy by Stifel: Advancing Obesity Portfolio
Tweet Send to a Friend
Stifel analyst Annabel Samimy reiterated a Buy rating and $50.00 price target on MBX Biosciences Inc (NASDAQ: MBX).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
